UPDATE 1-U.S. FDA rejects Chiasma's drug to treat growth disorder

April 15 (Reuters) - The U.S. Food and Drug Administration

has rejected Chiasma Inc's experimental drug to treat

adults with a type of growth disorder, the company said on

Friday.

Read more